PRDM2 and lung carcinoma: The epigenetic regulators that were newly found with recurrent mutations in our cohort, including CREBBP and PRDM2, have been separately identified as epigenetic regulators that could be targets in juvenile myelomonocytic leukemia35 and lung cancer.36 Further studies will be needed to investigate the functional roles of these genes in NPC.